These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25911301)

  • 1. Current kinase inhibitors cover a tiny fraction of fragment space.
    Zhao H; Caflisch A
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2372-6. PubMed ID: 25911301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enriching screening libraries with bioactive fragment space.
    Zhang N; Zhao H
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3594-7. PubMed ID: 27311891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
    Kolb P; Kipouros CB; Huang D; Caflisch A
    Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.
    van Linden OP; Farenc C; Zoutman WH; Hameetman L; Wijtmans M; Leurs R; Tensen CP; Siegal G; de Esch IJ
    Eur J Med Chem; 2012 Jan; 47(1):493-500. PubMed ID: 22137457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-based approaches to the discovery of kinase inhibitors.
    Mortenson PN; Berdini V; O'Reilly M
    Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pharmacophore Network: A Computational Method for Exploring Structure-Activity Relationships from a Large Chemical Data Set.
    Métivier JP; Cuissart B; Bureau R; Lepailleur A
    J Med Chem; 2018 Apr; 61(8):3551-3564. PubMed ID: 29648816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of fragments for kinase inhibitor design: decoration is key.
    Czodrowski P; Hölzemann G; Barnickel G; Greiner H; Musil D
    J Med Chem; 2015 Jan; 58(1):457-65. PubMed ID: 25437144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach.
    Badrinarayan P; Sastry GN
    J Mol Graph Model; 2012 Apr; 34():89-100. PubMed ID: 22306417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Design and Analysis of a Kinase-Focused Combinatorial Library Considering Diversity and Quality.
    Yang Y; Zhang Y; Hua Y; Chen X; Fan Y; Wang Y; Liang L; Deng C; Lu T; Chen Y; Liu H
    J Chem Inf Model; 2020 Jan; 60(1):92-107. PubMed ID: 31886658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the comprehensive systematic enumeration and synthesis of novel kinase inhibitors based on a 4-anilinoquinazoline binding mode.
    Kettle JG; Ward RA
    J Chem Inf Model; 2010 Apr; 50(4):525-33. PubMed ID: 20141221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
    Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
    J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors.
    Irie T; Sawa M
    Chem Pharm Bull (Tokyo); 2018; 66(1):29-36. PubMed ID: 29311509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors.
    Zhou T; Caflisch A
    ChemMedChem; 2010 Jul; 5(7):1007-14. PubMed ID: 20540063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting kinase profiling data to predict activity and understand cross-reactivity of kinase inhibitors.
    Niijima S; Shiraishi A; Okuno Y
    J Chem Inf Model; 2012 Apr; 52(4):901-12. PubMed ID: 22414491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Chem Biol Drug Des; 2007 Mar; 69(3):204-11. PubMed ID: 17441906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets.
    Baurin N; Aboul-Ela F; Barril X; Davis B; Drysdale M; Dymock B; Finch H; Fromont C; Richardson C; Simmonite H; Hubbard RE
    J Chem Inf Comput Sci; 2004; 44(6):2157-66. PubMed ID: 15554686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KID: A Kinase-Focused Interaction Database and Its Application in the Construction of Kinase-Focused Molecule Databases.
    Dai X; Xu Y; Qiu H; Qian X; Lin M; Luo L; Zhao Y; Huang D; Zhang Y; Chen Y; Liu H; Jiang Y
    J Chem Inf Model; 2022 Dec; 62(23):6022-6034. PubMed ID: 36447388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes.
    Michelotti EL; Moffett KK; Nguyen D; Kelly MJ; Shetty R; Chai X; Northrop K; Namboodiri V; Campbell B; Flynn GA; Fujimoto T; Hollinger FP; Bukhtiyarova M; Springman EB; Karpusas M
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5274-9. PubMed ID: 16169718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the Available Chemical Space versus the Chemical Universe of Lead-Like Compounds.
    Lin A; Horvath D; Afonina V; Marcou G; Reymond JL; Varnek A
    ChemMedChem; 2018 Mar; 13(6):540-554. PubMed ID: 29154440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinase hinge binding scaffolds and their hydrogen bond patterns.
    Xing L; Klug-Mcleod J; Rai B; Lunney EA
    Bioorg Med Chem; 2015 Oct; 23(19):6520-7. PubMed ID: 26358279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.